Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Myasthenia gravis (MG) is a rare disorder characterized by fluctuating muscle weakness with potential life‐threatening crises. Timely interventions may be delayed by limited access to care and fragmented documentation. Our objective was to develop predictive algorithms for MG deterioration using multimodal telemedicine data ...
Maike Stein +7 more
wiley +1 more source
Saccadic eye movements in neurological disease: cognitive mechanisms and clinical applications [PDF]
Yuanshang Wang +8 more
openalex +1 more source
Chronological and Spatial Distribution of Skeletal Muscle Fat Replacement in FHL1‐Related Myopathies
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objectives Variants in the FHL1 gene cause FHL1‐related myopathies (FHL1‐RMs), a group of neuromuscular disorders with diverse clinical presentations. This study aimed to comprehensively characterize the spatial and temporal patterns of skeletal muscle fat replacement throughout the whole body in FHL1‐RMs, to examine disease progression over ...
Rui Shimazaki +8 more
wiley +1 more source
Ocular Surface Changes Associated with Neurological Diseases. [PDF]
Medicina (Kaunas)Zemaitiene R, Gorgadze G, Mockaitiene L.
europepmc +1 more source
Nose-to-Brain Delivery of Antioxidants as a Potential Tool for the Therapy of Neurological Diseases [PDF]
, 2020 Maria Cristina Bonferoni +5 more
openalex +1 more source
Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To describe the use of central stimulants and amantadine for fatigue in MS and evaluate a potential association with reduced work loss in people with MS. Methods We conducted a nationwide, matched, register‐based cohort study in Sweden (2006 to 2023) using national registers with prospective data collection.
Simon Englund +3 more
wiley +1 more source
Ferroptosis-associated transcriptional factors in neurological diseases: molecular mechanisms and therapeutic prospects. [PDF]
Exp Mol MedJiang T, Ma W, Dong W, Zhou H, Mao X.
europepmc +1 more source
Review of cellular therapies provides new insights into the potential treatment of diverse neurologic diseases in horses and dogs [PDF]
Aimée C. Colbath +3 more
openalex +1 more source
Early diagnosis of neurological disease using peak degeneration ages of multiple biomarkers [PDF]
, 2019 Fei Gao, Yuanjia Wang, Donglin Zeng
openalex +1 more source